{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:57:09Z","timestamp":1781171829437,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,11]]},"DOI":"10.7759\/cureus.110645","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:05:24Z","timestamp":1781168724000},"source":"Crossref","is-referenced-by-count":0,"title":["Phase III Trials in India: A Comprehensive Analysis of the Clinical Trials Registry-India"],"prefix":"10.7759","author":[{"given":"Ajaya","family":"Sahoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash R","family":"Meher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monalisa","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa M","family":"Padhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.09.2475","article-title":"Key concepts of clinical trials: a narrative review","volume":"123","author":"Umscheid CA","year":"2011","unstructured":"Umscheid CA, Margolis DJ, Grossman CE. Key concepts of clinical trials: a narrative review. Postgrad Med. 2011, 123:194-204. 10.3810\/pgm.2011.09.2475","journal-title":"Postgrad Med"},{"key":"ref2","unstructured":"New Drugs and Clinical Trials Rules, 2019. (2019). Accessed. 2026: https:\/\/cdsco.gov.in\/opencms\/opencms\/en\/Acts-and-rules\/New-Drugs\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001407","article-title":"Number of patients studied prior to approval of new medicines: a database analysis","volume":"10","author":"Duijnhoven RG","year":"2013","unstructured":"Duijnhoven RG, Straus SM, Raine JM, de Boer A, Hoes AW, De Bruin ML. Number of patients studied prior to approval of new medicines: a database analysis. PLoS Med. 2013, 10:e1001407. 10.1371\/journal.pmed.1001407","journal-title":"PLoS Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.115373","article-title":"Clinical trials in India: where do we stand globally?","volume":"4","author":"Selvarajan S","year":"2013","unstructured":"Selvarajan S, George M, Kumar SS, Dkhar SA. Clinical trials in India: where do we stand globally?. Perspect Clin Res. 2013, 4:160-4. 10.4103\/2229-3485.115373","journal-title":"Perspect Clin Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2007.02.004","article-title":"Clinical trials in India","volume":"56","author":"Maiti R","year":"2007","unstructured":"Maiti R, M R. Clinical trials in India. Pharmacol Res. 2007, 56:1-10. 10.1016\/j.phrs.2007.02.004","journal-title":"Pharmacol Res"},{"key":"ref6","article-title":"How to register a clinical trial in India?","volume":"58","author":"Sil A","year":"2013","unstructured":"Sil A, Das NK. How to register a clinical trial in India?. Indian J Dermatol. 2013, 58:235-6.","journal-title":"Indian J Dermatol"},{"key":"ref7","article-title":"Registering clinical trials in India: a scientific and ethical imperative","volume":"21","author":"Tharyan P","year":"2008","unstructured":"Tharyan P, Ghersi D. Registering clinical trials in India: a scientific and ethical imperative. Natl Med J India. 2008, 21:31-4.","journal-title":"Natl Med J India"},{"key":"ref8","unstructured":"Frequently asked questions. (2026). Accessed. 2026: https:\/\/ctri.nic.in\/Clinicaltrials\/faq.php."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/picr.picr_124_23","article-title":"A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials","volume":"15","author":"Sabu ST","year":"2024","unstructured":"Sabu ST, Venkatraman S, Cherian JJ, et al.. A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials. Perspect Clin Res. 2024, 15:18-23. 10.4103\/picr.picr_124_23","journal-title":"Perspect Clin Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_89_20","article-title":"Has mandatory prospective registration of all studies brought about a change? A 1-year audit of studies registered in the Clinical Trials Registry of India [CTRI] before and after April 1, 2018","volume":"12","author":"Shetty NS","year":"2021","unstructured":"Shetty NS, Salvi RA, Thatte UM, Gogtay NJ. Has mandatory prospective registration of all studies brought about a change? A 1-year audit of studies registered in the Clinical Trials Registry of India [CTRI] before and after April 1, 2018. Perspect Clin Res. 2021, 12:72-5. 10.4103\/picr.PICR_89_20","journal-title":"Perspect Clin Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/picr.picr_150_24","article-title":"The landscape of phase IV clinical trials in India - a comprehensive analysis of the Clinical Trial Registry-India","volume":"16","author":"Meher BR","year":"2025","unstructured":"Meher BR, Rout BK, Ponnusamy S, Mohanty RR, Padhy BM. The landscape of phase IV clinical trials in India - a comprehensive analysis of the Clinical Trial Registry-India. Perspect Clin Res. 2025, 16:138-42. 10.4103\/picr.picr_150_24","journal-title":"Perspect Clin Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.198551","article-title":"Regulatory environment for clinical research: recent past and expected future","volume":"8","author":"Bhave A","year":"2017","unstructured":"Bhave A, Menon S. Regulatory environment for clinical research: recent past and expected future. Perspect Clin Res. 2017, 8:11-6. 10.4103\/2229-3485.198551","journal-title":"Perspect Clin Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ija.IJA_143_17","article-title":"Regulatory requirements for clinical trials in India: what academicians need to know","volume":"61","author":"Gogtay NJ","year":"2017","unstructured":"Gogtay NJ, Ravi R, Thatte UM. Regulatory requirements for clinical trials in India: what academicians need to know. Indian J Anaesth. 2017, 61:192-9. 10.4103\/ija.IJA_143_17","journal-title":"Indian J Anaesth"},{"key":"ref14","unstructured":"The New Drugs and Clinical Trials Rules, 2019. (2019). Accessed. 2026: https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2022\/new_DC_rules\/NEW%20DRUGS%20ANDctrS%20RULE,%202019.pdf."},{"key":"ref15","unstructured":"Guideline for good clinical practice E6(R3). (2025). Accessed. 2026: https:\/\/database.ich.org\/sites\/default\/files\/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07683-3","article-title":"Generation of allocation sequences in randomised trials: chance, not choice","volume":"359","author":"Schulz KF","year":"2002","unstructured":"Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet. 2002, 359:515-9. 10.1016\/S0140-6736(02)07683-3","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials","volume":"125","author":"Hariton E","year":"2018","unstructured":"Hariton E, Locascio JJ. Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials. BJOG. 2018, 125:1716. 10.1111\/1471-0528.15199","journal-title":"BJOG"},{"key":"ref18","unstructured":"Choice of control group and related issues in clinical trials E10. (2000). Accessed. 2026: https:\/\/database.ich.org\/sites\/default\/files\/E10_Guideline.pdf."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subjects. JAMA. 2013, 310:2191-4. 10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford I","year":"2016","unstructured":"Ford I, Norrie J. Pragmatic trials. N Engl J Med. 2016, 375:454-63. 10.1056\/NEJMra1510059","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018320","article-title":"Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov","volume":"8","author":"Bothwell LE","year":"2018","unstructured":"Bothwell LE, Avorn J, Khan NF, Kesselheim AS. Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov. BMJ Open. 2018, 8:e018320. 10.1136\/bmjopen-2017-018320","journal-title":"BMJ Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3126\/nje.v10i3.31622","article-title":"Impact of COVID-19 on clinical trials and clinical research: a systematic review","volume":"10","author":"Sathian B","year":"2020","unstructured":"Sathian B, Asim M, Banerjee I, et al.. Impact of COVID-19 on clinical trials and clinical research: a systematic review. Nepal J Epidemiol. 2020, 10:878-87. 10.3126\/nje.v10i3.31622","journal-title":"Nepal J Epidemiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/picr.picr_380_20","article-title":"A survey to assess the impact of the COVID-19 pandemic and the resultant lockdown measures on the ongoing clinical trials in India","volume":"12","author":"Gupta J","year":"2021","unstructured":"Gupta J, Dadhania RN. A survey to assess the impact of the COVID-19 pandemic and the resultant lockdown measures on the ongoing clinical trials in India. Perspect Clin Res. 2021, 12:175-6. 10.4103\/picr.picr_380_20","journal-title":"Perspect Clin Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108634","article-title":"COVID-19: a review of therapeutic strategies and vaccine candidates","volume":"222","author":"Izda V","year":"2021","unstructured":"Izda V, Jeffries MA, Sawalha AH. COVID-19: a review of therapeutic strategies and vaccine candidates. Clin Immunol. 2021, 222:108634. 10.1016\/j.clim.2020.108634","journal-title":"Clin Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.07.021","article-title":"SARS-CoV-2 vaccine development: current status","volume":"95","author":"Poland GA","year":"2020","unstructured":"Poland GA, Ovsyannikova IG, Crooke SN, Kennedy RB. SARS-CoV-2 vaccine development: current status. Mayo Clin Proc. 2020, 95:2172-88. 10.1016\/j.mayocp.2020.07.021","journal-title":"Mayo Clin Proc"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00093-1","article-title":"Impact of COVID-19 on oncology clinical trials","volume":"19","author":"Upadhaya S","year":"2020","unstructured":"Upadhaya S, Yu JX, Oliva C, Hooton M, Hodge J, Hubbard-Lucey VM. Impact of COVID-19 on oncology clinical trials. Nat Rev Drug Discov. 2020, 19:376-7. 10.1038\/d41573-020-00093-1","journal-title":"Nat Rev Drug Discov"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33220-9","article-title":"Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study","volume":"395","author":"DeVito NJ","year":"2020","unstructured":"DeVito NJ, Bacon S, Goldacre B. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study. Lancet. 2020, 395:361-9. 10.1016\/S0140-6736(19)33220-9","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008932","article-title":"Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013","volume":"5","author":"Viergever RF","year":"2015","unstructured":"Viergever RF, Li K. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013. BMJ Open. 2015, 5:e008932. 10.1136\/bmjopen-2015-008932","journal-title":"BMJ Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496509-phase-iii-trials-in-india-a-comprehensive-analysis-of-the-clinical-trials-registry-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:05:35Z","timestamp":1781168735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496509-phase-iii-trials-in-india-a-comprehensive-analysis-of-the-clinical-trials-registry-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.110645","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}